Latest News and Press Releases

Third Quarter 2025 Highlights1 Revenues of $409.2 millionNet Income of $2.6 million, a net income margin of 0.6%, includes $6.3 million of expenses related to the acquisition of Sterling Check Corp....

Lexeo Therapeutics Reports Third Quarter 2025 Financial Results and Operational Highlights

ATLANTA, Oct. 16, 2025 (GLOBE NEWSWIRE) -- First Advantage Corporation (NASDAQ: FA), a leading provider of global software and data in the HR technology industry, will issue its third quarter 2025...

Lexeo Therapeutics Announces Progress in FDA Discussions for Accelerated Approval and Positive Interim Clinical Data for LX2006 in FA Cardiomyopathy

Lexeo Therapeutics Reports Second Quarter 2025 Financial Results and Operational Highlights

ATLANTA, July 17, 2025 (GLOBE NEWSWIRE) -- First Advantage Corporation (NASDAQ: FA), a leading provider of global software and data in the HR technology industry, will issue its second quarter 2025...

Lexeo Therapeutics Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia

ATLANTA, May 27, 2025 (GLOBE NEWSWIRE) -- First Advantage Corporation (NASDAQ: FA), a leading provider of global software and data in the HR technology industry, will host its inaugural Investor Day...

ATLANTA, May 20, 2025 (GLOBE NEWSWIRE) -- First Advantage Corporation (NASDAQ: FA), a leading provider of global software and data in the HR technology industry, today announced that the Company’s...

First Quarter 2025 Highlights1 Revenues of $354.6 millionNet Loss of $(41.2) million, a net loss margin of (11.6)%, includes $15.3 million of expenses related to the acquisition of Sterling Check...